Veterinary Medicines

Alvebuton 100 mg/ml Solution for injection for cattle, pigs, horses, sheep, goats

Authorised
  • Menbutone
Download as PDF

Product identification

Medicine name:
ALVEBUTON 100 MG/ML SOLUTION FOR INJECTION
Alvebuton 100 mg/ml Solution for injection for cattle, pigs, horses, sheep, goats
Active substance:
  • Menbutone
Target species:
  • Cattle (calf)
  • Pig
  • Horse
  • Sheep
  • Goat
  • Cattle
Route of administration:
  • Intramuscular use
  • Intravenous use

Product details

Active substance and strength:
  • Menbutone
    100.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle (calf)
      • Meat and offal
        0
        day
    • Pig
      • Meat and offal
        0
        day
    • Horse
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Sheep
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Goat
      • Meat and offal
        0
        day
      • Milk
        0
        day
  • Intravenous use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Pig
      • Meat and offal
        0
        day
    • Horse
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Sheep
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Goat
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Cattle (calf)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA05AX90
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Package description:
  • Box containing 1 bottle of 100 mL
  • Box containing 10 bottles of 100 mL

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • V.M.D.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratoires Biove
  • V.M.D.
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA16142/003/001
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0292/001
Concerned member states:
  • Austria
  • Belgium
  • Croatia
  • Germany
  • Ireland
  • Italy
  • Luxembourg
  • Netherlands
  • Romania
  • Spain